Medtronic Revenue 2010-2023 | MDT
Medtronic annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medtronic revenue for the quarter ending January 31, 2023 was $7.727B, a 0.46% decline year-over-year.
- Medtronic revenue for the twelve months ending January 31, 2023 was $30.772B, a 3.19% decline year-over-year.
- Medtronic annual revenue for 2022 was $31.686B, a 5.21% increase from 2021.
- Medtronic annual revenue for 2021 was $30.117B, a 4.16% increase from 2020.
- Medtronic annual revenue for 2020 was $28.913B, a 5.38% decline from 2019.
Medtronic Annual Revenue
(Millions of US $) |
| 2022 |
$31,686 |
| 2021 |
$30,117 |
| 2020 |
$28,913 |
| 2019 |
$30,557 |
| 2018 |
$29,953 |
| 2017 |
$29,710 |
| 2016 |
$28,833 |
| 2015 |
$20,261 |
| 2014 |
$17,005 |
| 2013 |
$16,590 |
| 2012 |
$16,184 |
| 2011 |
$15,508 |
| 2010 |
$15,392 |
| 2009 |
$14,599 |
Medtronic Quarterly Revenue
(Millions of US $) |
| 2023-01-31 |
$7,727 |
| 2022-10-31 |
$7,585 |
| 2022-07-31 |
$7,371 |
| 2022-04-30 |
$8,089 |
| 2022-01-31 |
$7,763 |
| 2021-10-31 |
$7,847 |
| 2021-07-31 |
$7,987 |
| 2021-04-30 |
$8,188 |
| 2021-01-31 |
$7,775 |
| 2020-10-31 |
$7,647 |
| 2020-07-31 |
$6,507 |
| 2020-04-30 |
$5,997 |
| 2020-01-31 |
$7,717 |
| 2019-10-31 |
$7,706 |
| 2019-07-31 |
$7,493 |
| 2019-04-30 |
$8,146 |
| 2019-01-31 |
$7,546 |
| 2018-10-31 |
$7,481 |
| 2018-07-31 |
$7,384 |
| 2018-04-30 |
$8,144 |
| 2018-01-31 |
$7,369 |
| 2017-10-31 |
$7,050 |
| 2017-07-31 |
$7,390 |
| 2017-04-30 |
$7,916 |
| 2017-01-31 |
$7,283 |
| 2016-10-31 |
$7,345 |
| 2016-07-31 |
$7,166 |
| 2016-04-30 |
$7,567 |
| 2016-01-31 |
$6,934 |
| 2015-10-31 |
$7,058 |
| 2015-07-31 |
$7,274 |
| 2015-04-30 |
$7,304 |
| 2015-01-31 |
$4,318 |
| 2014-10-31 |
$4,366 |
| 2014-07-31 |
$4,273 |
| 2014-04-30 |
$4,565 |
| 2014-01-31 |
$4,163 |
| 2013-10-31 |
$4,194 |
| 2013-07-31 |
$4,083 |
| 2013-04-30 |
$4,460 |
| 2013-01-31 |
$4,027 |
| 2012-10-31 |
$4,095 |
| 2012-07-31 |
$4,008 |
| 2012-04-30 |
$4,297 |
| 2012-01-31 |
$3,918 |
| 2011-10-31 |
$4,023 |
| 2011-07-31 |
$3,946 |
| 2011-04-30 |
$3,975 |
| 2011-01-31 |
$3,857 |
| 2010-10-31 |
$3,903 |
| 2010-07-31 |
$3,773 |
| 2010-04-30 |
$3,770 |
| 2010-01-31 |
$3,851 |
| 2009-10-31 |
$3,838 |
| 2009-07-31 |
$3,933 |
| 2009-04-30 |
$3,829 |
| 2009-01-31 |
$3,494 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$105.915B |
$31.686B |
|
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
|
